Correspondence 0001213900-24-093776 from ShoulderUP Technology Acquisition Corp. (SUAC, SUACU, SUACW) (CIK 0001885461)
ShoulderUP Technology Acquisition Corp. (SUAC, SUACU, SUACW) (CIK 0001885461)
Date: Nov. 4, 2024 · CIK: 0001885461 · Accession: 0001213900-24-093776
AI Filing Summary & Sentiment
File numbers found in text: 001-41076
Referenced dates: November 1, 2024
Show Raw Text
CORRESP
1
filename1.htm
ShoulderUp Technology Acquisition Corp.
125 Townpark Drive
Suite 300
Kennesaw, Georgia
30144
November 4, 2024
VIA OVERNIGHT COURIER
AND EDGAR
U.S. Securities
and Exchange Commission
Division of Corporation
Finance
100 F Street, N.E.
Washington, D.C.
20549-3628
Attention:
Stacie Gorman
Jeffrey Gabor
Re:
ShoulderUp Technology Acquisition Corp.
Preliminary Proxy
Statement on Schedule 14A
Filed October
24, 2024
File No. 001-41076
Ladies and Gentlemen:
This letter is submitted in response to the comments
of the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) as
set forth in the Staff’s comment letter dated November 1, 2024 (the “Comment Letter”), in respect of ShoulderUp
Technology Acquisition Corp.’s (“we”, “us”, “our” or the “Company”)
Preliminary Proxy Statement on Schedule 14A, filed with the Commission on October 24, 2024 (the “Proxy Statment”).
The responses to the Comment Letter are set forth
below, with each paragraph numbered to correspond to the comment number set forth in the Comment Letter. For your convenience, the comments
have been reproduced below, together with our responses.
In addition, the Company has revised the Proxy
Statement in response to the Staff’s comments and is filing an amendment to the Proxy Statement (the “Amendment”)
concurrently with this letter, which reflects the revisions and clarifies certain other information. The page numbers in the text of the
Company’s responses correspond to the page numbers in the Amendment. Unless otherwise indicated, capitalized terms used herein
have the meanings assigned to them in the Amendment.
Preliminary
Proxy Statement on Schedule 14A
General
1.
Staff’s comment: We note that your shares were
delisted from the NYSE on December 29, 2023, and
that you became quoted on the OTC Market Group pink sheets on March
6, 2024. We also note your disclosure references that you are listed on the NYSE. Please revise throughout to clarify that you are quoted
on the pink sheets of OTC Market Group Inc. Further, please add disclosure, including risk factor disclosure, to address the consequences
of being delisted, including that your stock may be determined to be a penny stock and the consequences of that designation, that you
may no longer be attractive as a merger partner because you are no longer listed on an exchange, any potential impact on your ability
to complete an initial business combination, any impact on the market for your securities including demand and overall liquidity for your
securities, and any impact on securities holders due to your securities no longer
being considered “covered securities.”
Response: The Company respectfully
acknowledges the Staff’s comment and has revised the disclosure in the Letter to Stockholders, Notice of Special Meeting of
Stockholders and on pages 3, 4, 5, 10, 23, 24 and 25 of the Amendment.
* * *
2
We hope that the foregoing responses address the issues raised in the
Comment Letter and would be happy to discuss with you any remaining questions or concerns that you may have. Please contact Penny Minna
at (410) 580-4228 should you have any questions concerning this letter or require further information.
Very truly yours,
/s/ Phyllis Newhouse
Phyllis Newhouse
Chief Executive Officer
ShoulderUp Technology Acquisition Corp.
cc:
Penny Minna, Esq.
DLA Piper LLP (US)
3